Women who have symptoms of breast cancer are sometimes referred to BreastScreen
Aotearoa (BSA) by their GP, or self refer to the programme. However, this has a
number of risks, including that the breast cancer may not be detected by a
mammogram and that there will be a delay in the diagnosis of breast cancer.
Dr Madeleine Wall, Clinical Leader, BreastScreen Aotearoa.
A key objective of the National Cervical Screening Programme (NCSP) is to reduce the incidence of cervical cancer by detecting precancerous high grade squamous intra-epithelial lesions (HSIL). Monitoring trends in HSIL detection is critical to understanding the epidemiology of cervical cancer in New Zealand and to evaluating the performance of the NCSP.
This overview of workforce development for BreastScreen Aotearoa (BSA) Medical Radiation Technologists (MRTs) and radiologists is part of the wider workforce initiatives for health professionals within the Ministry of Health.
This systematic review identified and appraised the international evidence for surveillance of women at high risk of breast cancer. The accuracy and health outcome of the following modalities of surveillance were assessed in comparison to normal care: mammography (XRM), ultrasound (US) and magnetic resonance imaging (MRI).